The Estimation of Prevalence, Incidence, and Residual Risk of Transfusion-Transmitted Human Hepatitis B Infection from Blood Donated at the Anhui Blood Center, China, from 2009 to 2011

被引:9
|
作者
Li, Wuping [1 ,2 ,3 ]
Gao, Zhan [2 ,3 ]
Yang, Chunhui [2 ,3 ]
Li, Jiahu [4 ]
Li, Ling [4 ]
Lv, Rong [4 ]
Liu, Zhong [2 ,3 ,4 ]
机构
[1] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Inst Blood Transfus, Beijing 100730, Peoples R China
[4] Anhui Blood Ctr, Hefei, Anhui, Peoples R China
来源
PLOS ONE | 2013年 / 8卷 / 09期
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; C VIRUS; VIRAL-INFECTIONS; DONORS; IMPACT;
D O I
10.1371/journal.pone.0073472
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The high prevalence of hepatitis B virus (HBV) among the Chinese population poses a threat to blood safety; however, few studies have examined epidemiological data regarding HBV infection of Chinese blood donors. The present study investigated the demographic characteristics of blood donors at the Anhui blood center in China, the prevalence, incidence, and residual risk (RR) associated with hepatitis B surface antigen (HBsAg) expression in terms of transfusion transmitted HBV (TTHBV) infections. Methods: The demographic characteristics and HBV status of people who donated blood at the Anhui blood center between 2009 and 2011 were retrospectively analyzed. The incidence of HBV was estimated through HBsAg yield approach. The window period model was then used to estimate the RR of TTHBV infection. Results: The typical donor at the Anhui blood center was a first-time volunteer, aged less than 25 years, unmarried, of Han ethnicity, and with an education below high school level. The prevalence of HBV infection among repeat donors, first-time donors, and all donors was 28.9, 127.2 and 82.1 per 100,000, respectively. The incidence estimate was 333.9 per 105 person-years. Using an infectious window period of 59 days, the RR for HBV was estimated to be 1 in 1853 between 2009 and 2011. Conclusions: The incidence and RR of HBV in Chinese blood donors are much higher than those of donors in developed countries. This is because sensitive ELISAs and nucleic acid tests are not available in China. Further work is needed to improve both the safety and availability of blood products in China.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Residual risk of transfusion-transmitted hepatitis B virus (TT-HBV) infection by NAT-screened blood components: A review of observed versus modeled infectivity from donors with window period and occult HBV infections
    Lelie, Nico
    Busch, Michael
    Kleinman, Steve
    TRANSFUSION, 2021, 61 (11) : 3190 - 3201
  • [42] Current incidence and residual risk of hepatitis B infection among blood donors in the United States
    Zou, Shimian
    Stramer, Susan L.
    Notari, Edward P.
    Kuhns, Mary C.
    Krysztof, David
    Musavi, Fatemeh
    Fang, Chyang T.
    Dodd, Roger Y.
    TRANSFUSION, 2009, 49 (08) : 1609 - 1620
  • [43] Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008
    Lafeuillade, Bruno
    Eb, Francois
    Ounnoughene, Nadra
    Petermann, Rachel
    Daurat, Gerald
    Huyghe, Gerard
    Mai-Phuong Vo Mai
    Caldani, Cyril
    Rebibo, Danielle
    Weinbreck, Pierre
    TRANSFUSION, 2015, 55 (03) : 636 - 646
  • [44] Transmissibility of Hepatitis B Virus (HBV) Infection through Blood Transfusion from Blood Donors with Occult HBV Infection
    Yuen, Man-Fung
    Wong, Danny Ka-Ho
    Lee, Cheuk-Kwong
    Tanaka, Yasuhito
    Allain, Jean-Pierre
    Fung, James
    Leung, Jennifer
    Lin, Che-Kit
    Sugiyama, Masaya
    Sugauchi, Fuminaka
    Mizokami, Masashi
    Lai, Ching-Lung
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (05) : 624 - 632
  • [45] Prevalence, incidence and residual risk of transfusion transmitted viruses (HBV, HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018: The incidence/window-period model study
    Grubyte, Samanta
    Urboniene, Jurgita
    Nedzinskiene, Laura
    Jelinskaite, Auguste
    Zagminas, Kestutis
    Ambrozaitis, Arvydas
    Jancoriene, Ligita
    PLOS ONE, 2021, 16 (02):
  • [46] Risk of Transfusion-Transmitted Infection with Severe Acute Respiratory Syndrome Coronavirus 2 from Blood Donors in Japan (vol 64, pg 116, 2024)
    Shinohara, N.
    Ito, M.
    Kai, K.
    Kamo, N.
    Owada, T.
    Sobata, R.
    Yamagishi, N.
    Takahashi, H.
    Ikeda, Y.
    Sawai, H.
    Furuta, R. A.
    Matsubayashi, K.
    Hino, I
    Goto, N.
    Satake, M.
    TRANSFUSION, 2024, 64 (05) : 958 - 958
  • [47] A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening
    Seed, C. R.
    Kiely, P.
    VOX SANGUINIS, 2013, 105 (04) : 290 - 298
  • [48] A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route
    Matsubayashi, Keiji
    Kang, Jong-Hon
    Sakata, Hidekatsu
    Takahashi, Kazuaki
    Shindo, Motohiro
    Kato, Masaru
    Sato, Shinichiro
    Kato, Toshiaki
    Nishimori, Hiroyuki
    Tsuji, Kunihiko
    Maguchi, Hiroyuki
    Yoshida, Jun-ichi
    Maekubo, Hiroshi
    Mishiro, Shunji
    Ikeda, Hisami
    TRANSFUSION, 2008, 48 (07) : 1368 - 1375
  • [49] Is tattooing associated with increased seroprevalence of transfusion-transmitted infections among blood donors: A single-center study from Southeastern India
    Arjunan, Charumathy
    Basavarajegowda, Abhishekh
    ASIAN JOURNAL OF TRANSFUSION SCIENCE, 2024, 18 (01) : 85 - 90
  • [50] Characterization of Occult Hepatitis B Virus Infection from Blood Donors in China
    Zheng, Xin
    Ye, Xianlin
    Zhang, Ling
    Wang, Wenjing
    Shuai, Lifang
    Wang, Anqi
    Zeng, Jinfeng
    Candotti, Daniel
    Allain, Jean-Pierre
    Li, Chengyao
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (05) : 1730 - 1737